Getting Back To Normal
US Rapid Testing
With the current COVID crisis, US Rapid Testing in conjunction with GenTech Laboratories is here to assist with your COVID testing needs. Our COVID testing options include our Rapid Antigen Testing with results typically available within 15 minutes and RT-PCR Testing which results can be made available within 24-48 hours from the laboratory receiving the specimen. Cut off time for RT-PCR testing is at 3pm each day. This allows us to ensure that the specimens can reach the laboratory by the next morning. Should you test after 3pm your test may experience a delay in reaching the lab. Please be aware that US Rapid Testing cannot guarantee the delivery of the specimen to the laboratory during times of inclement weather. We will try our best to work with you so that you can get your results as soon as possible in these instances. Our patients may schedule an appointment at one of our 3 locations in the Valley by visiting our website usrapidtesting.com
Be ready to return to work.
If you need help keeping your employees, guests and customers safe, contact us today at firstname.lastname@example.org. We’ll be happy to answer any questions you have.
Types Of Testing For COVID-19
This Antigen Test detects viral proteins. The rapid antigen test reveals patients at the peak of the infection when the body has the highest concentration of the protein. This test is faster and less expensive than the molecular test. Specificity is 98.2% – 99% and Sensitivity 82.5% – 96%.
The disadvantage is that they are not as sensitive (accurate) as the standard RT-PCR tests used to accurately identify those infected. When using them, a significant percentage of those infected pass the test as a false negative. In a few days, these people will spread the virus among others, thinking they are healthy.
US Rapid Testing does NOT guarantee an individual result. These tests are not 100% accurate. RT-PCR testing is available should an individual want to take a test with the highest accuracy.
RT-PCR (Real-Time Reverse Transcription–Polymerase Chain Reaction):
Detects the presence of viral RNA. It is very accurate and efficient. This test can detect COVID-19 during early infectious stages and will allow for early isolation. Thus, this method can prevent the transmission of the virus to other hosts. It is the more accurate test but can take longer for the results to come back. Specificity is >99% and Sensitivity >98%.
Rapid Antigen Covid-19 Testing
Make a same-day appointment or just show up during business hours. Receive your results in about 15 minutes.
Stay in your car for the nasal swab test.
Automated CDC-compliant lab results and reporting.
Don’t wait with our drive-thru labs with more convenient locations near you opening soon.
Safe, secure, easy, and contactless booking, payment, and private secure email results.
Swab sample taken from lower nasal area not upper sinus cavity.
Protect Your Business
COVID-19 has impacted nearly every aspect of American life. It’s clear that both proactive screening and quick and reliable testing are going to be primary weapons to stop the spread, invaluable tools in bringing our businesses back to life, and a way to help us find The Right Way to Return to Work.
US Rapid Testing is here to help you every step of the way!
We provide screening and monitoring solutions, pooled (surveillance) testing, fast and reliable COVID-19/SARS CoV2 testing, consultations with healthcare providers and advice on how to keep everyone around you safe and healthy. We can help you re-open your business safely and in a way your employees and customers will know you’re doing all you can for them.
Frequently Asked Questions
We are adding new convenient locations around Arizona almost daily. Click the “Book Appointment” button for the zip code search for the most current location near you. You will stay in your car in our designated parking spaces and wait for the lab attendant.
A positive test result for this COVID-19 test indicates that antigens from SARS-CoV-2 were detected, and the patient is infected with the virus and presumed to be contagious. Patients should follow current CDC guidelines and contact their doctor or further instruction. If you test positive for COVID-19, know what protective steps to take if you are sick or caring for someone. If you would like a local telehealth doctor recommendation, please inquire at email@example.com
Serving clients and patients nationwide, GenTech is a premier diagnostic laboratory dedicated to service excellence. Keeping service excellence at the forefront of our processes, we are committed to providing stellar quality and paramount services. GenTech has an expert clinical and management team ensuring best practices designed to concisely promote specimen integrity. We offer a multifaceted approach of testing services. GenTech uses state of the art laboratory machines, automated computer systems and a highly skilled technical staff to deliver accurate, reliable and fast results. We provide solutions to ensure the entire process from order entry to case sign-out nothing less than world class.
For much of the pandemic, Harvard epidemiologist Michael Mina has been just about the country’s biggest and most enthusiastic proponent of mass testing. For most of the year, the country has been relying on PCR testing, which is relatively expensive and typically returns results in (at best) a few days. In some places, there has also been rapid molecular testing, which works on the same basis as a PCR test — it looks for viral RNA, and can pick up even very small amounts, which means almost no one receives a false negative result. But for the last few months, Mina has been especially focused on the public-health potential of a different method, the rapid antigen test, which functionally measures infectiousness — rather than infection — and which is extremely cheap and easy to use. The closest analogy is an at-home pregnancy test — not quite as clinically reliable as a pregnancy test in a doctor’s office, but so much more affordable, available, and easy to access that it allows for a massive expansion of testing capacity. In mid-November, Mina argued that large-scale deployment could stop the spread of COVID-19 by Christmas — many months before even the most optimistic timeline of vaccine rollout could be completed.